Letter to the Editors: Concerning "Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia" by Lee et al.

Brooks, Elizabeth D; Kishnani, Priya S; Koeberl, Dwight D

Brooks, Elizabeth D; Kishnani, Priya S; Koeberl, Dwight D.

Afiliação

Brooks ED; Division of Medical Genetics, Duke University Medical Center, DUMC Box 103856, Durham, NC, 27710, USA.
Kishnani PS; Division of Laboratory Animal Resources, Duke University Medical Center, Durham, NC, USA.
Koeberl DD; Division of Medical Genetics, Duke University Medical Center, DUMC Box 103856, Durham, NC, 27710, USA.

J Inherit Metab Dis ; 41(6): 913-914, 2018 11.

Article em En | MEDLINE | ID: mdl-30255460

Assuntos

Doença de Depósito de Glicogênio Tipo I; Animais; Cães; Terapia Genética

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Depósito de Glicogênio Tipo I Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google